Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2007.372 | A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of A Single Treatment with Two Dose Levels of BOTOXｮ (Botulinum Toxin Type A) Purified Neurotoxin Complex Followed By A Treatment with BOTOXｮ in Patients with Urinary Incontinence due to Neurogenic Detrusor Overactivity | Prof. Chan Chi Kwok |
| 2006.270 | ONTARGET and TRANSCEND Study (Protocol No. 502.373) | CHAN Chi Kin Hamish |
| 2004.387 | The Impact of Assistive Technology on the Community Particiation and Quality of Life of People with Spinal Cord Injury | CHAN Chi Chung Sam |
| 2005.254 | A Parallel-Group, Multi-Centre, Active-Controlled (Glibenclamide) Long Term Extension Study to Evaluate the Safety and Tolerability of Oral Tesaglitazar Therapy in Patients with Type 2 Diabetes Mellitus (GALLEX 4) | Prof. Chan C.N. Juliana |
| 2004.183 | A 52-Week Randomized, Double-blind, Parallel-Group, Multi-Centre, Active-Controlled (Glibenclamide) Study to Evaluate the Efficacy, Safety and Tolerability of Tesaglitazar Therapy when Administered to Patients with Type 2 Diabetes | Prof. Chan C.N. Juliana |
| 2005.255 | A Long-Term, Post Treatment, Safety Follow-up, Multi-Centre Study in Patients with Type 2 Diabetes Mellitus from the GALLANT, GALLEX or ARMOR Studies G-PLUS (GALLANT, GALLEX and ARMOR | Prof. Chan C.N. Juliana |
| 2004.182 | A 24-Week Randomized, Double-blind, Double-dummy, Multicenter Study to Compare the Efficacy of Extended Release AVANDIA_ (8mg OD) and Immediate-Release AVANDIA (8mg OD) in Subjects with Type 2 Diabetes Mellitus | Prof. Chan C.N. Juliana |
| 2005.138 | International Diabetes Management Practices Study, The | Prof. Chan C.N. Juliana |
| 2003.356 | CS-866 DM (Olmesartan) Phase III Study: A Double-blind, Placebo-Controlled Trial in Patients with Diabetic Nephropathy and Overt Proteinuria Secondary to Type 2 Diabetes | Prof. Chan C.N. Juliana |
| 2002.468 | "A Multicentre, Double-Blind, Ranomized, Placebo-and Active-Controlled, Parallel Study to Evaluate the Glucose and Lipid-Altering Efficacy and Safety of L-410198 in Patients with Type 2 Diabetes" and An Extension to : "A Multicentre, Double-Blind, Ranomized, Placebo-and Active-Controlled, Parallel Study to Evaluate the Glucose and Lipid-Altering Efficacy and Safety of L-410198 in Patients with Type 2 Diabetes" | Prof. Chan C.N. Juliana |
| 2004.055 | Molecular Characterization of Putative Oncogenes in Medulloblastoma | CHAN Bik Wan Amy |
| 2003.372 | A Phase III Randomized, Open-Label, Multicenter Study of Irinotecan and Cetuximab vs. Irinotecan as Second-Line Treatment in Patients with Metastatic, EGFR-Positive Colorectal Carcinoma | Prof. Chan Anthony |
| 2004.447 | Phase III Randomized Trial of Concomitant Radiation, Cisplatin, and Tirapazamine (SR259075) Versus Concomitant Radiation and Cisplatin in Patients with Advanced Head and Neck Cancer | Prof. Chan Anthony |
| 2007.098 | A Phase 3 Randomized Trial of Chemotherapy With or Without Panitumumab in Patients with Metastatic and/or Recurrent Squamous Cell Carcinoma of the Heart and Neck | Prof. Chan Anthony |
| 2004.248 | Biweekly Gemcitabine and Oxaliplatin (GEMOX) in First-line Metastatic or Recurrent Nasopharyngeal Carcinoma (NPC) | Prof. Chan Anthony |
| 2003.219 | LY582563 and Lamivudine Interaction Study in Lamivudine-Resistant Hepatitis B Virus(HBV) Patients | Prof. Chan Lik Yuen Henry |
| 2005.438 | Health Related Quality of Life of Pacemaker Patients in Hong Kong | CHAIR Sek Ying |
| 2006.086 | The Effect of Motivational Interviewing on the Clinical Outcomes, Psychological Outcomes and Health-related Quality of Life of Clients Receiving Cardiac Rehabilitation | CHAIR Sek Ying |
| 2006.399 | The Effect of Motivational Interviewing on the Clinical Outcomes, Psychological Outcomes and Health-related Quality of Life of Cardiac, Rehabilitation Clients with Poor Motivation | CHAIR Sek Ying |
| 2008.291 | Derivation and Validation of a Clinical Decision Rule for Identifying Critically Ill Patients in the Emergency Department | CATTERMOLE Giles |
| 2003.286 | Quality of Life, Cost Effectiveness, Survival and Functional Outcomes Following Differential Management of Laryngeal Cancer | Prof. C.A. Van Hasselt |
| 2007.202 | Stem Cell Strategies in Burns Care: Human Umbilical Cord Blood and Cord Lining Cells | BURD Andrew |
| 2006.190 | Targeting Apoptosis: A Study of Laser Indcution and Hyaluronan Modulation in Keloid Derived Cells | BURD Andrew |
| 2006.284 | Assessing Facial Function in Chinese Patients with Facial Burns: The Facial Functional Impairment Index | BURD Andrew |
| 2006.434 | An Investigation of the Potential Therapeutic Application of Human Umbilical Cord Lining Epithelium for the Reconstruction of the Skin and Buccal Mucosal Epithelial Defects | BURD Andrew |
| 2008.178 | An Investigation of the Plasticity of Human Umbilical Cord Lining for Epithelial Reconstitution | BURD Andrew |
| 2004.162 | An Investigation of the Role of Epidermal Stem Cells in Modulating Epithelial-Mesenchymal Networks in Post-burn Keloid Scarring | BURD Andrew |
| 2004.433 | An Evaluation of Foetal Stem Cell Interactions with Post Natal Keratinocytes and Dermal Fibroblasts | BURD Andrew |
| 2007.308 | Multi-Dose Study to Investigate Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profiles of DU-176b in Chinese Healthy Male Adult Subjects | Prof. Briant Tomlinson |
| 2007.245 | Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose Ranging Phase 2 Study to Investigate Efficacy, Safety, Tolerability and Pharmacokinetics of the DPP-IV Inhibitor RO4876904 in Patients with Type 2 Diabetes | Prof. Brian Tomlinson |
| 2007.244 | Clinical Bioequivalence Study on Two Acarbose Formulations | Prof. Brian Tomlinson |
| 2006.095 | Reduced Factorial Design, Randomized, Double Blind Trial Comparing Combinations of Telmisartan 20 or 80 mg and Simvastatin 20 or 40 mg with Single Component Therapies in the Treatment of Hypertension and Dyslipidemia | Prof. Brian Tomlinson |
| 2004.348 | Comparison of Clinical Efficacy of Two Formulations of Hypromellose (Hydroxypropyl Methylcellulose) | Prof. Brian Tomlinson |
| 2005.368 | A Randomized, Single-Dose, Open-Label, Two-Way Crossover Study to Investigate the Pharmacokinetics of HPD-333-A Transdermal System in Healthy Subjects | Prof. Brian Tomlinson |
| 2007.271 | A Multicenter, Randomized, Double-Blind, | Prof. Brian Tomlinson |
| 2005.148 | Phase I Study on the Safety and Pharmacokinetics of IMD-1041 in Healthy Male Volunteers | Prof. Brian Tomlinson |
| 2004.371 | An Open-Label 7-Day Study to Determine the Influence of CYP2C19 Genotype on the Pharmacokinetics of RO2052349 in Patients with Type 2 Diabetes Mellitus in the Asia-Pacific Region | Prof. Brian Tomlinson |
| 2006.422 | A Multi-Center, Doubled-Blind, Randomized, Placebo-Controlled, Dose-Ranging Phase 2 Study to Investigate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of RO5073031 in Patients with Type 2 Diabetes Mellitus Treated with A Stable Dose of Metformin | Prof. Brian Tomlinson |
| 2003.265 | An Open-Label, Randomized, Multi-Centre, Phase IIIb/IV, Parallel Group Study to Compare the Efficacy and Safety of Rosuvastatin and Atorvastatin in Subjects with Type IIa and IIb Hypercholesterolaemia | Prof. Brian Tomlinson |
| 2005.110 | A Randomized, Double-blind, Two-arms Placebo-controlled, Parallel-group, Multicenter Study of Rimonabant 20mg Once Daily in the Treatment of Atherogenic Dyslipidemia in Abdoninally Obese Patients | Prof. Brian Tomlinson |
| 2005.370 | Pharmacokinetics of Single and Repeated Oral Administration of S 18886 30mg Daily in Chinese Healthy Male Volunteers | Prof. Brian Tomlinson |
| 2007.281 | A Comparative Pharmacokinetic Study of Cilostazol SR Capsule with Pletaal Tablet in Healthy Male Subjects | Prof. Brian Tomlinson |
| 2003.178 | Safety, Viremia, and Immunogenicity of Low -(10-2 TCID-50) and High- (10-4 TCID-50) Virus Concentration Monovalent Vero Dengue-3 Vaccine Versus Stamaril® (Aventis Pasteur Yellow Fever Vaccine) in Flavivirus Na_ve Healthy Adults | Prof. Brian Tomlinson |
| 2008.505 | A Multi-center, Double-blind, Randomized, Parallel Group, Placebo-controlled 12-week Study to Investigate Glycemic Parameters of Efficacy, Safety/Tolerability and Pharmacokinetics of Five Dose Levels of RO4998452 in Patients with Type 2 Diabetes Mellitus | Prof. Brian Tomlinson |
| 2005.231 | Study of Pharmacogenetics, Pharmacodynamics and Population Pharmacokinetics of Rosuvastatin in Chinese Patients with Hyperlipidaemia | Prof. Brian Tomlinson |
| 2004.086 | Study of the Effects of Lingzhi Therapy on Cardiovascular, Metabolic, Antioxidant and Inflammation Parameters in Hypertensive and Hyperlipidemic Patients | Prof. Brian Tomlinson |
| 2004.087 | A Placebo Controlled, Randomized Study to Examine the Impact of 24-Week Orlistat Treatment on Postprandial Triglyceridaemia, Steatohepatitis and Cardiovascular Risk Factors in Overweight Chinese Patients | Prof. Brian Tomlinson |
| 2005.456 | Phase I Study on the Study and Pharmacokinetics of Single and Repeated Application of IMD-0354 in Health Male Volunteers | Prof. Brian Tomlinson |
| 2005.111 | Prediction of Blood Pressure Response to Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blocker by Phenotypic and Genotypic Determinants in Chinese Patients with Type 2 Diabetes, Borderline Hypertension and Microalbuminuria | Prof. Brian Tomlinson |
| 2005.120 | Comparison of Lercanidipine with Nifedipine Slow Release in Essential Hypertension | Prof. Brian Tomlinson |
Page 288 of 289.